Medistat has been working with biotechnology and pharmaceutical companies for over 25 years, providing a wide variety of professional statistical and data management services for medical research
(pharmaceutical and medical devices).
Medistat is involved in development process from pre-clinical phase through phase I, phase II, phase III and phase IV (post-marketing surveillance-PMS).
Dr. Tami Wolf Goldberg
Tami joined Medistat in 2013. She graduated with a PhD in Medical Sciences from Tel Aviv University. Tami specializes in CRF and clinical database design, medical coding, medical monitoring and medical writing.
Dr. Gil Harari
CEO & Founder
Gil founded Medistat in 1995.
He graduated with a PhD in Epidemiology and bio-statistics from Haifa University.
Gil specializes in bio-statistics and data mining. He is also the author of the book "Statistics in Medicine".